Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;109(Pt B):209-218.
doi: 10.1016/j.nbd.2017.07.018. Epub 2017 Jul 24.

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies

Affiliations
Review

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies

Chao Peng et al. Neurobiol Dis. 2018 Jan.

Abstract

The deposition of misfolded β-sheet enriched amyloid protein is a shared feature of many neurodegenerative diseases. Recent studies demonstrated the existence of conformationally diverse strains as a common property for multiple amyloidogenic proteins including α-Synuclein (α-Syn). α-Syn is misfolded and aggregated in a group of neurodegenerative diseases collectively known as α-Synucleinopathies, which include Parkinson's disease (PD), dementia with Lewy body, multiple system atrophy and also a subset of Alzheimer's disease patients with concomitant PD-like Lewy bodies and neurites. While sharing the same pathological protein, different α-Synucleinopathies demonstrate distinct clinical and pathological phenotypes, which could result from the existence of diverse pathological α-Syn strains in patients. In this review, we summarized the characteristics of different α-Synucleinopathies and α-Syn strains generated with recombinant α-Syn monomers. We also make predictions of α-Syn strains that could potentially exist in patients based on the knowledge from other amyloid proteins and the clinical and pathological features of different α-Synucleinopathies.

Keywords: Dementia with Lewy body; Multiple system atrophy; Parkinson's disease; Protein aggregates; α-Synuclein strains; α-Synucleinopathy.

PubMed Disclaimer

Figures

Figure 1
Figure 1. α-Synuclein aggregations in different α-Synucleinopathies
(A) Structural features of α-Synuclein. The N-terminal, NAC and C-terminal domain are highlighted in blue, yellow and green squares respectively. The five PD-related point mutations (A53T, A30P, E46K, H50Q, G51D) are marked in red. The seven hexameric motifs are underlined in purple. (B) α-Synuclein aggregations strained by anti-α-Synuclein antibody (303) in different α-Synucleinopathies. PD: Parkinson’s disease; SN: Substantia nigra; DLB: dementia with Lewy body; Ctx: Cortex; MSA: multiple system atrophy; CB: Cerebellum; GCI: Glial cytoplasmic inclusion; NI: Neuronal inclusion; AD: Alzheimer’s disease; Amg: Amygdala; iLB: Incidental LB disease. Scale bar: 25μm.
Figure 2
Figure 2. Different α-Synuclein strains generated from recombinant proteins
De novo generated α-Syn aggregates under physiological salt concentrations have a cylindrical aspect (Strain A), while those obtained under low salt concentrations are flat (Ribbons). Repeat seeding of Strain A fiber lead to the generation of Strain B fiber, which could cross seed tau aggregation in neurons.

References

    1. Aarsland D, et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60:387–92. - PubMed
    1. Abeliovich A, et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 2000;25:239–52. - PubMed
    1. Aguzzi A, et al. Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol. 2007;8:552–61. - PubMed
    1. Ahmed Z, et al. The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol. 2012;38:4–24. - PubMed
    1. Apaydin H, et al. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol. 2002;59:102–12. - PubMed

MeSH terms

Substances